DRUGDRUG
INFORMATIONINFORMATION
SERVICESSERVICES
Dr. AMREEN SABAATTARIYA
POST GRADUATE STUDENT
DEPT OF PHARMACOLOGY
M.R. MEDICAL COLLEGE, GULBARGA
INDIA
OUTLINE
Introduction
History
DIC
Information Sources
Answering of queries
Drug Information Bulletin
Summary
References
Apr 12, 2016 2Dr.ASA:DrugInfoServices
INTRODUCTIONINTRODUCTION
Growth of medical information at an
alarming rate.
Vast data by FDA & from clinical
investigations.
Decision to chosing the best information.
WHOdeveloped DIC to promote
rational use of drugs*
*Promoting rational use of medicines: core components. WHO Policy
Perspectives on Medicines, September 2002Apr 12, 2016 3Dr.ASA:DrugInfoServices
DRUG INFORMATIONDRUG INFORMATION
The Provision Of Written And/Or Verbal
Information About Drugs And Drug
Therapy In Response To A Request From
Other Healthcare Providing Organizations,
Committees, Patients, And Public
Community
Apr 12, 2016 4Dr.ASA:DrugInfoServices
Drug information center(DIC)Drug information center(DIC)
Provides in-depth, unbiased
source of crucial drug
information to meet needs of the
practicing physicians, pharmacists
and other health care
professionals
Apr 12, 2016 5Dr.ASA:DrugInfoServices
MISSIONMISSION
To increase the community
knowledge & awareness about drug
& drug usage
Apr 12, 2016 6Dr.ASA:DrugInfoServices
HISTORYHISTORY:
 First DIC at University of Kentucky in 1960.
In US- 80% of the Hospitals have DIC.
Apr 12, 2016 7Dr.ASA:DrugInfoServices
INDIAN SCENARIO*INDIAN SCENARIO*
WHO India country office + KSPC
(Karnataka State Pharmacy Council)
5 DIC in India
Haryana (Sirsa)
Chhattisgarh(Raipur)
Rajasthan (Jaipur)
Assam (Dibrugarh)
Goa(Panaji)
Apr 12, 2016 8Dr.ASA:DrugInfoServices
*Chauhan N:Indian aspects of drug information resources & impact of DIC on
community, J. Adv. Pharm. Tech. Res
Ideal DIC serviceIdeal DIC service
Gear to the need of its users.
Information- dependable, timely &
standard.
Expertise should be readily accesible.
SOPs for categorising enquiries &
maintaining search pattern.
OPTIMAL USAGE OF DRUG
INFORMATION
Apr 12, 2016
11
Dr.ASA:DrugInfoServices
STAFFINGSTAFFING
Pharmacy team:
Pharmacist
Pharmacy Technicians & Students
Medical team:
Toxicologists
Clinical pharmacologist
Supporting team:
People trained in library science with
computer knowledge
Apr 12, 2016 12Dr.ASA:DrugInfoServices
OBJECTIVES OF DICOBJECTIVES OF DIC
1. Promote evidence based practice.
2. Meet the patient’s needs while
providing pharmaceutical care
Apr 12, 2016 13Dr.ASA:DrugInfoServices
3. Improve the patient adherence
4. To provide accurate and unbiased
information.
5. To provide an organized database.
Apr 12, 2016 14Dr.ASA:DrugInfoServices
AVAILABLE INFORMATION IN DIC
 General
 Pharmacological
 Toxicity
 Formulation
 Pharmacokinetics
 Adverse effects
 General
 Pharmacological
 Toxicity
 Formulation
 Pharmacokinetics
 Adverse effects
Apr 12, 2016 15Dr.ASA:DrugInfoServices
SOURCES OF INFORMATION
Apr 12, 2016 16Dr.ASA:DrugInfoServices
Apr 12, 2016 17Dr.ASA:DrugInfoServices
1. PRIMARY SOURCE:
 Original information
 Scientific Journals
 Thesis
 Proceedings of conferences
Apr 12, 2016 18Dr.ASA:DrugInfoServices
2. SECONDARY SOURCE2. SECONDARY SOURCE::
Database(pubmed,embase, scopus,
toxline,National Library of Medicine Gateway)
Low drug information
services[http://www.uiowa.edu/~idin/]
Review articles.
Apr 12, 2016 19Dr.ASA:DrugInfoServices
3.TERTIARY SOURCE:
Textbooks on drug or disease topics
 Pharmacopeias - IP, BP, USP, BNF etc.,
 Encyclopedia
 Dictionaries
 Guides
Apr 12, 2016 20Dr.ASA:DrugInfoServices
Other Sources::
 Public and hospitals about the AE of any drug.
 Local drug lists
 National formularies, Hospital formularies
 Internet
 Phone calls to manufacturers, government and
non-government organizations & to other DIC.
Apr 12, 2016 21Dr.ASA:DrugInfoServices
SERVICES OFFERED:
 Information about drugs.
 Poison management information.
 Patient education service.
 Assistance on drug usage in patients.
 Professional assistance for investigations in drug usage.
 Drug related information to hospital staff.
 Reporting and investigating ADR.
Apr 12, 2016 22Dr.ASA:DrugInfoServices
Steps in Answering
Apr 12, 2016 23Dr.ASA:DrugInfoServices
Indian Journal of Pharmacy Practice ; Volume 4; Issue 2; Pg.53.
Apr 12, 2016 24Dr.ASA:DrugInfoServices
Indian Journal of Pharmacy Practice ; Volume 4; Issue 2; Pg.53.
Apr 12, 2016 25Dr.ASA:DrugInfoServices
Indian Journal of Pharmacy Practice ; Volume 4; Issue 2; Pg.53.
Apr 12, 2016 26Dr.ASA:DrugInfoServices
DRUG INFORMATION BULLETIN
For transmission of information to the members of
health care team.
 Regular publication is needed on the latest
developments.
Apr 12, 2016 28Dr.ASA:DrugInfoServices
Illegal DIC*Illegal DIC*
Report the abused drugs for victimizing
some innocent.
Illinois State Police has started this to
report such cases of drug abuse & spread
awareness in both public & US officials to
ban such drugs OTC selling.
Governed by DEA (Drug Enforcement
Administration)
Apr 12, 2016 Dr.ASA:DrugInfoServices 29
*Available from: http://www.justice.gov/dea/pubs/abuse/index.htm
[Last accessed on 2012 Oct 7].
SummarySummary
DICs are regarded as a gateway of
drug information.
They have responsibility to provide
highest possible std information.
Sources of information.
DICs aim at rational use of drugs.
A proper working DIC is necessary
to make best use of its services.
Apr 12, 2016 30Dr.ASA:DrugInfoServices
ReferencesReferences
Wooten J: sources of drug information, Nov
2012.
Requirements of DIC: FIP Pharmacy
Information Section
Chauhan N et al, Indian aspects of drug
information resources & impact of DIC on
community:J. Adv. Pharm. Tech. Res. Apr-Jun
2013,Vol 4,Issue 2
Promoting rational use of medicines: core
components. WHO Policy Perspectives on
Medicines, September 2002Apr 12, 2016 31Dr.ASA:DrugInfoServices

Drug Information Services

  • 1.
    DRUGDRUG INFORMATIONINFORMATION SERVICESSERVICES Dr. AMREEN SABAATTARIYA POSTGRADUATE STUDENT DEPT OF PHARMACOLOGY M.R. MEDICAL COLLEGE, GULBARGA INDIA
  • 2.
    OUTLINE Introduction History DIC Information Sources Answering ofqueries Drug Information Bulletin Summary References Apr 12, 2016 2Dr.ASA:DrugInfoServices
  • 3.
    INTRODUCTIONINTRODUCTION Growth of medicalinformation at an alarming rate. Vast data by FDA & from clinical investigations. Decision to chosing the best information. WHOdeveloped DIC to promote rational use of drugs* *Promoting rational use of medicines: core components. WHO Policy Perspectives on Medicines, September 2002Apr 12, 2016 3Dr.ASA:DrugInfoServices
  • 4.
    DRUG INFORMATIONDRUG INFORMATION TheProvision Of Written And/Or Verbal Information About Drugs And Drug Therapy In Response To A Request From Other Healthcare Providing Organizations, Committees, Patients, And Public Community Apr 12, 2016 4Dr.ASA:DrugInfoServices
  • 5.
    Drug information center(DIC)Druginformation center(DIC) Provides in-depth, unbiased source of crucial drug information to meet needs of the practicing physicians, pharmacists and other health care professionals Apr 12, 2016 5Dr.ASA:DrugInfoServices
  • 6.
    MISSIONMISSION To increase thecommunity knowledge & awareness about drug & drug usage Apr 12, 2016 6Dr.ASA:DrugInfoServices
  • 7.
    HISTORYHISTORY:  First DICat University of Kentucky in 1960. In US- 80% of the Hospitals have DIC. Apr 12, 2016 7Dr.ASA:DrugInfoServices
  • 8.
    INDIAN SCENARIO*INDIAN SCENARIO* WHOIndia country office + KSPC (Karnataka State Pharmacy Council) 5 DIC in India Haryana (Sirsa) Chhattisgarh(Raipur) Rajasthan (Jaipur) Assam (Dibrugarh) Goa(Panaji) Apr 12, 2016 8Dr.ASA:DrugInfoServices *Chauhan N:Indian aspects of drug information resources & impact of DIC on community, J. Adv. Pharm. Tech. Res
  • 9.
    Ideal DIC serviceIdealDIC service Gear to the need of its users. Information- dependable, timely & standard. Expertise should be readily accesible. SOPs for categorising enquiries & maintaining search pattern. OPTIMAL USAGE OF DRUG INFORMATION Apr 12, 2016 11 Dr.ASA:DrugInfoServices
  • 10.
    STAFFINGSTAFFING Pharmacy team: Pharmacist Pharmacy Technicians& Students Medical team: Toxicologists Clinical pharmacologist Supporting team: People trained in library science with computer knowledge Apr 12, 2016 12Dr.ASA:DrugInfoServices
  • 11.
    OBJECTIVES OF DICOBJECTIVESOF DIC 1. Promote evidence based practice. 2. Meet the patient’s needs while providing pharmaceutical care Apr 12, 2016 13Dr.ASA:DrugInfoServices
  • 12.
    3. Improve thepatient adherence 4. To provide accurate and unbiased information. 5. To provide an organized database. Apr 12, 2016 14Dr.ASA:DrugInfoServices
  • 13.
    AVAILABLE INFORMATION INDIC  General  Pharmacological  Toxicity  Formulation  Pharmacokinetics  Adverse effects  General  Pharmacological  Toxicity  Formulation  Pharmacokinetics  Adverse effects Apr 12, 2016 15Dr.ASA:DrugInfoServices
  • 14.
    SOURCES OF INFORMATION Apr12, 2016 16Dr.ASA:DrugInfoServices
  • 15.
    Apr 12, 201617Dr.ASA:DrugInfoServices
  • 16.
    1. PRIMARY SOURCE: Original information  Scientific Journals  Thesis  Proceedings of conferences Apr 12, 2016 18Dr.ASA:DrugInfoServices
  • 17.
    2. SECONDARY SOURCE2.SECONDARY SOURCE:: Database(pubmed,embase, scopus, toxline,National Library of Medicine Gateway) Low drug information services[http://www.uiowa.edu/~idin/] Review articles. Apr 12, 2016 19Dr.ASA:DrugInfoServices
  • 18.
    3.TERTIARY SOURCE: Textbooks ondrug or disease topics  Pharmacopeias - IP, BP, USP, BNF etc.,  Encyclopedia  Dictionaries  Guides Apr 12, 2016 20Dr.ASA:DrugInfoServices
  • 19.
    Other Sources::  Publicand hospitals about the AE of any drug.  Local drug lists  National formularies, Hospital formularies  Internet  Phone calls to manufacturers, government and non-government organizations & to other DIC. Apr 12, 2016 21Dr.ASA:DrugInfoServices
  • 20.
    SERVICES OFFERED:  Informationabout drugs.  Poison management information.  Patient education service.  Assistance on drug usage in patients.  Professional assistance for investigations in drug usage.  Drug related information to hospital staff.  Reporting and investigating ADR. Apr 12, 2016 22Dr.ASA:DrugInfoServices
  • 21.
    Steps in Answering Apr12, 2016 23Dr.ASA:DrugInfoServices
  • 22.
    Indian Journal ofPharmacy Practice ; Volume 4; Issue 2; Pg.53. Apr 12, 2016 24Dr.ASA:DrugInfoServices
  • 23.
    Indian Journal ofPharmacy Practice ; Volume 4; Issue 2; Pg.53. Apr 12, 2016 25Dr.ASA:DrugInfoServices
  • 24.
    Indian Journal ofPharmacy Practice ; Volume 4; Issue 2; Pg.53. Apr 12, 2016 26Dr.ASA:DrugInfoServices
  • 25.
    DRUG INFORMATION BULLETIN Fortransmission of information to the members of health care team.  Regular publication is needed on the latest developments. Apr 12, 2016 28Dr.ASA:DrugInfoServices
  • 26.
    Illegal DIC*Illegal DIC* Reportthe abused drugs for victimizing some innocent. Illinois State Police has started this to report such cases of drug abuse & spread awareness in both public & US officials to ban such drugs OTC selling. Governed by DEA (Drug Enforcement Administration) Apr 12, 2016 Dr.ASA:DrugInfoServices 29 *Available from: http://www.justice.gov/dea/pubs/abuse/index.htm [Last accessed on 2012 Oct 7].
  • 27.
    SummarySummary DICs are regardedas a gateway of drug information. They have responsibility to provide highest possible std information. Sources of information. DICs aim at rational use of drugs. A proper working DIC is necessary to make best use of its services. Apr 12, 2016 30Dr.ASA:DrugInfoServices
  • 28.
    ReferencesReferences Wooten J: sourcesof drug information, Nov 2012. Requirements of DIC: FIP Pharmacy Information Section Chauhan N et al, Indian aspects of drug information resources & impact of DIC on community:J. Adv. Pharm. Tech. Res. Apr-Jun 2013,Vol 4,Issue 2 Promoting rational use of medicines: core components. WHO Policy Perspectives on Medicines, September 2002Apr 12, 2016 31Dr.ASA:DrugInfoServices

Editor's Notes

  • #15 3. Improve the patient adherence (To promote patient care through the rational use of medicines) . 5. To provide an organized database of specialized information on medicines & therapeutics
  • #29 It publishes the latest developments in medical sciences, the newly introduced drugs, new indication and other information regarding drugs. Pharmacist is normally held responsible for its publication however; contributions are obtained from pharmacists, physicians and nursing and other interested groups like therapeutic dietician for food drug interactions for publishing the bulletin.